Pfizer Inc
Stocks making the biggest moves midday: Generac, Amazon, Pfizer and more
Check out the companies making headlines in midday trading: Generac Holdings — Shares of the maker of power generators surged 8% as Hurricane Milton intensified into a Category 5 storm . Amazon — The e-commerce stock lost 2.9% after Wells Fargo downgraded shares to equal weight from overweight and cut its price target, citing slowing […]
Read More
Stocks making the biggest moves premarket: Apple, Amazon, Pfizer, Hershey and more
Check out the companies making headlines before the bell. Apple — Shares declined 1.4% after Jefferies downgraded the megacap tech company to hold from buy, saying near-term expectations for the iPhone 16 and 17 are too high after weaker-than-expected initial demand. Apple’s AI capabilities leading to an accelerated smartphone replacement cycle is a “premature” catalyst, […]
Read More
CNBC Daily Open: September’s blockbuster jobs report changes the calculus
More than 75 employers were taking resumes and talking to prospective new hires at a career fair in Lake Forest, CA on Wednesday, February 21, 2024. Paul Bersebach | Medianews Group | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on […]
Read More
Activist Starboard Value has $1 billion Pfizer stake, taps former executives for help, sources say
People pass by the Pfizer headquarters building in New York City, Jan. 29, 2023. Kena Betancur | View Press | Corbis News | Getty Images Activist investor Starboard Value has a roughly $1 billion stake in pharmaceutical giant Pfizer and is seeking to mount a turnaround at the struggling company, according to people familiar with […]
Read More
Cheap stocks to buy in the fourth quarter, according to HSBC
It’s officially a new trading month, and HSBC recommends investors broaden their exposure in the fourth quarter by seeking out stocks with more reasonable valuations. September was another winning month for stocks, as the S & P 500 saw its fifth consecutive month in the green. On the final trading day of the month, the […]
Read More
A recession is imminent and favored tech stocks set to crater like the ‘Nifty Fifty’ did, BCA Research says
The rise and fall of the “Nifty Fifty” stocks in the 1970s is a cautionary tale for investors in the Magnificent Seven craze, according to BCA Research. The “Nifty Fifty” refers to a loose group of stocks including Coca-Cola , IBM , Xerox and Pfizer , that rose to prominence in the 1970 to 1973 […]
Read More
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
Kena Betancur | Corbis News | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Hello and happy Tuesday! Today, we’re unpacking a shocking move from Pfizer. The pharmaceutical giant last week announced it […]
Read More
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the “frenzy” of weight loss drugs, preferring instead to focus on areas where it can build a “unique position.” Speaking to CNBC, Vas Narasimhan said that the company was researching treatments that deal with the secondary effects of […]
Read More
5 things to know before the stock market opens Monday
Here are the most important news items that investors need to start their trading day: 1. The Fed’s up Jerome Powell at Jackson Hole on August 23, 2024. David A. Grogan | CNBC The long-awaited Federal Reserve interest rate cut may finally arrive this week. The central bank’s policymakers are set to announce Wednesday whether they […]
Read More
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
Pfizer‘s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said Saturday. Patients with the condition, called cancer cachexia, who took Pfizer’s treatment saw improvements in body weight, muscle mass, quality of life and physical function, according to […]
Read More